FDA names new women’s health director

The FDA has named Kathleen Uhl, M.D., as the new director of its Office of Women's Health (OWH).
Uhl, a captain in the U.S. Public Health Service, most recently served as a supervisory medical officer in the FDA's Center for Drug Evaluation and Research (CDER) and has been with the agency since 1998.
Her predecessor, Susan Wood, quit August 31 after the agency delayed its decision whether to permit OTC sales of Barr's Plan B emergency contraceptive, despite a Sept. 1 deadline set by former commissioner Lester Crawford. Wood maintained that the delay was politically motivated, although in a subsequent Associated Press interview she said she wasn't sure on whose authority the decision was made.
A second FDA staff member who resigned in protest of the agency's handling of Plan B, Frank Davidoff, said he thinks the decision was made on the basis of political pressure rather than science.
Crawford's resignation came in late September, prior to Davidoff's.
Uhl will take office next month, relieving Theresa Toigo, head of the FDA's Office of Special Health Issues, who had been acting OWH director.
You must be a registered member of MMM to post a comment.
close

Next Article in Careers

Email Newsletters


Investment in healthcare IT stands at an all-time high. The government has spent billions to promote EHR adoption. Yet the physician wish list is a mile long, while hospitals and patients are not where they need to be. To peel back the layers of what we've all been waiting for in the Great Data Capture of the 21st Century, and to review the changes enabling the healthcare data ecosystem to coexist, MM&M presents this e-Book. Click here.


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.